Sign up for free insights newsletter
PI

Premier Inc

PINCUnited States

Need professional-grade analysis? Visit stockanalysis.com

$20.43
-1.21%
End of day
Market Cap

$2.34B

P/E Ratio

166.24

Employees

2,700

Dividend Yield

2.97%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.980.27-0.29
Calmar-1.540.29-0.52
Sharpe-0.980.23-0.31
Omega0.401.180.84
Martin-2.140.59-0.62
Ulcer21.8315.0018.03

Premier Inc (PINC) Price Performance

Premier Inc (PINC) trades on United States in USD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at $20.43, down 1.21% from the previous close.

Over the past year, PINC has traded between a low of $18.62 and a high of $28.25. The stock has gained 9.7% over this period. It is currently 27.7% below its 52-week high.

Premier Inc has a market capitalization of $2.34B, with a price-to-earnings ratio of 166.24 and a dividend yield of 2.97%.

About Premier Inc

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. The company offers solutions for providers, such as group purchasing organization, supply chain optimization, margin improvement, workforce management, care transformation, value-based care, and provider collaboratives; for suppliers, such as group purchasing organization and digital supply chain; for life sciences, such as real-world evidence, research, real-world data, healthcare professional, engagement solutions, improvement science, and premier applied sciences team; and for payers, such as coding guide for payers, prior authorization, and gaps. It offers services, including data and analytics, supply chain solutions, software-as-a-service informatics and consulting, and group purchasing. It serves a network of hospitals, health systems, and other healthcare providers. The company was incorporated in 2013 and is based in Charlotte, North Carolina. As of November 25, 2025, Premier, Inc. operates as a subsidiary of Patient Square Capital, LP.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$1.00B
EBITDA
$271.82M
Profit Margin
-3.28%
EPS (TTM)
0.17
Book Value
18.48

Technical Indicators

52 Week High
$28.79
52 Week Low
$18.37
50 Day MA
$28.01
200 Day MA
$23.35
Beta
0.61

Valuation

Trailing P/E
166.24
Forward P/E
20.04
Price/Sales
2.33
Price/Book
1.53
Enterprise Value
$2.62B